Showing results (71-80 of 118) with videos related to
Sort By:
Pageof 12
Clinical Nutrition (Edinburgh, Scotland)|October 16, 2020
Acute effects of delayed-release hydrolyzed pine nut oil on glucose tolerance, incretins, ghrelin and appetite in healthy humansKarina V Sørensen, Svend S Korfitzen, Mads H Kaspersen, et al.The Journal of Biological Chemistry|November 12, 2016
Molecular Mechanism of Action for Allosteric Modulators and Agonists in CC-chemokine Receptor 5 (CCR5)Stefanie Karlshøj, Roxana Maria Amarandi, Olav Larsen, et al.Journal of Medicinal Chemistry|August 23, 2011
Identification of a potent and selective free fatty acid receptor 1 (FFA1/GPR40) agonist with favorable physicochemical and in vitro ADME propertiesElisabeth Christiansen, Christian Urban, Manuel Grundmann, et al.Journal of Medicinal Chemistry|May 2, 2023
Discovery of Potent Tetrazole Free Fatty Acid Receptor 2 AntagonistsAlice Valentini, Katrine Schultz-Knudsen, Anders Højgaard Hansen, et al.Journal of Medicinal Chemistry|December 13, 2006
Novel selective orally active CRTH2 antagonists for allergic inflammation developed from in silico derived hitsTrond Ulven, Jean-Marie Receveur, Marie Grimstrup, et al.ACS Pharmacology & Translational Science|April 8, 2020
Selective Allosteric Modulation of N-Terminally Cleaved, but Not Full Length CCL3 in CCR1Olav Larsen, Michael Lückmann, Wijnand J C van der Velden, et al.Journal of Medicinal Chemistry|August 11, 2023
Identification of 5-HT2 Serotonin Receptor Modulators through the Synthesis of a Diverse, Tropane- and Quinuclidine-alkaloid-Inspired Compound LibraryRuwei Yao, Anders A Jensen, Hogan P Bryce-Rogers, et al.Molecular Pharmacology|August 28, 2013
The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonismBrian D Hudson, Bharat Shimpukade, Amanda E Mackenzie, et al.Journal of Neuroinflammation|April 28, 2017
Polyunsaturated fatty acid receptors, GPR40 and GPR120, are expressed in the hypothalamus and control energy homeostasis and inflammationNathalia R V Dragano, Carina Solon, Albina F Ramalho, et al.Journal of Medicinal Chemistry|September 25, 2018
Discovery of a Potent Thiazolidine Free Fatty Acid Receptor 2 Agonist with Favorable Pharmacokinetic PropertiesAnders Højgaard Hansen, Eugenia Sergeev, Daniele Bolognini, et al.Pageof 12